Gene therapy/CAR-T breakdown. Bluebird falls on GBT news

Gene therapy and car-t are leading the way in new potential treatments of blood disorders. I breakdown how these techniques work and which companies are using the technology.

Follow me @matthewlepoire


*This is not trading advice*


Novartis buys Avexis!

-Novartis buys gene therapy company, Avexis for $8.7 billion

-Spark is another gene therapy company I like, involved in hemophilia and eye-related blindness diseases

Follow me on twitter @matthewlepoire

%d bloggers like this: